All In Biotech

Drug Trial Radar · NCT05723198

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of Baricitinib in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 595 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

595

Planned (sponsor's estimate)

Start

Feb 27, 2023

Primary completion

Mar 2028

Study completion Sep 2033

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Feb 10, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 6 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hair loss) in children from 6 years to less than 18 years of age. The study is divided into 4 periods, a 5-week Screening period, a 36-week Double-Blind Treatment Period, an approximately 2-year Long-term Extension (LTE) Period, and a 4-week Post-treatment Follow-up period. Some individuals may be eligible to receive treatment after completing the LTE, for a maximum of 180 weeks.

Conditions

  • Areata Alopecia
  • Alopecia
  • Hypotrichosis
  • Hair Diseases
  • Skin Diseases
  • Pathological Conditions, Anatomical

Interventions

  • BaricitinibDrug

    Administered orally

  • PlaceboDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving an Absolute Severity of Alopecia Tool (SALT) ≤20Time frame: Week 36

Locations

127 sites in 12 countries. Site status is shown where the registry gives one.

  • Total Skin and Beauty Dermatology Center, PC

    Birmingham, Alabama · Recruiting

  • University of Alabama at Birmingham

    Birmingham, Alabama · Not yet recruiting

  • Investigate MD

    Scottsdale, Arizona · Recruiting

  • California Dermatology & Clinical Research Institute

    Encinitas, California · Not yet recruiting

  • Dermatology Research Associates

    Los Angeles, California · Recruiting

  • University of California, San Diego/Rady Children's Hospital, San Diego - Pediatric & Adolescent Dermatology

    San Diego, California · Recruiting

  • The Permanente Medical Group, Inc.

    San Francisco, California · Recruiting

  • Southern California Dermatology, Inc.

    Santa Ana, California · Recruiting

  • Dermatology Physicians of Connecticut

    Fairfield, Connecticut · Not yet recruiting

  • Skin Care Research, Inc

    Boca Raton, Florida · Not yet recruiting

  • Florida Academic Centers Research and Education, LLC

    Coral Gables, Florida · Completed

  • D&H Doral Research Center LLC

    Doral, Florida · Not yet recruiting

  • Skin Care Research, Inc

    Hollywood, Florida · Not yet recruiting

  • Solutions Through Advanced Research, Inc.

    Jacksonville, Florida · Recruiting

  • University of Miami Miller School of Medicine

    Miami, Florida · Not yet recruiting

  • Pediatric Skin Research, LLC

    Miami, Florida · Recruiting

  • Skin Care Physicians of Georgia

    Macon, Georgia · Recruiting

  • Northwestern University

    Chicago, Illinois · Not yet recruiting

  • Northshore University Healthsystem

    Skokie, Illinois · Recruiting

  • Dawes Fretzin Clinical Research Group, LLC

    Indianapolis, Indiana · Recruiting

  • The South Bend Clinic Center for Research

    South Bend, Indiana · Recruiting

  • DermAssociates PC.

    Rockville, Maryland · Recruiting

  • Michigan Center for Research Company

    Clarkston, Michigan · Recruiting

  • University of Minnesota Medical School

    Minneapolis, Minnesota · Recruiting

  • MediSearch Clinical Trials

    Saint Joseph, Missouri · Recruiting

  • Advanced Skin Research Center

    Omaha, Nebraska · Recruiting

  • Montefiore Medical Center

    The Bronx, New York · Recruiting

  • Dermatology Specialists of Charlotte

    Charlotte, North Carolina · Recruiting

  • OnSite Clinical Solutions

    Charlotte, North Carolina · Completed

  • Bexley Dermatology Research

    Bexley, Ohio · Recruiting

  • Cincinnati Childrens Hospital Medical Center

    Cincinnati, Ohio · Not yet recruiting

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio · Not yet recruiting

  • Vital Prospects Clinical Research Institute, P.C.

    Tulsa, Oklahoma · Recruiting

  • Northwest Dermatology Institute

    Portland, Oregon · Recruiting

  • The Pennsylvania Centre for Dermatology, LLC

    Exton, Pennsylvania · Completed

  • Medical University of South Carolina

    Charleston, South Carolina · Recruiting

  • International Clinical Research - Tennessee (IC Research)

    Murfreesboro, Tennessee · Recruiting

  • Dermatology Treatment and Research Center

    Dallas, Texas · Not yet recruiting

  • Pediatric Dermatology of North Texas

    Grapevine, Texas · Recruiting

  • Texas Dermatology and Laser Specialists

    San Antonio, Texas · Recruiting

Showing 40 of 127 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.